0001203311-17-000056.txt : 20170825
0001203311-17-000056.hdr.sgml : 20170825
20170825195210
ACCESSION NUMBER: 0001203311-17-000056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170824
FILED AS OF DATE: 20170825
DATE AS OF CHANGE: 20170825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRACHMAN JONATHAN G
CENTRAL INDEX KEY: 0001588467
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 171052956
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2017-08-24
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001588467
DRACHMAN JONATHAN G
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
CMO & EVP, R & D
Common Stock
2017-08-24
4
M
0
10000
10.29
A
152204
D
Common Stock
2017-08-24
4
S
0
10000
47.5414
D
142204
D
Non-Qualified Stock Option (right to buy)
10.29
2017-08-24
4
M
0
10000
0.0
D
2017-08-28
Common Stock
10000
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $47.29 to $47.88. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Shares vested at a rate of 25% on 8/28/2007 and monthly thereafter until all the shares were fully vested on 8/28/2011.
/s/ Jean Liu
2017-08-25